Brief: Forward Pharma enters license agreement with 2 units of Biogen and other parties

Forward Pharma A/S

01/02/2017 14:17

Feb 1 (Reuters) - Forward Pharma A/S  FWP.O  
    * Approved entry into settlement, license agreement with 2 
wholly owned subsidiaries of Biogen Inc and certain other 
parties 
    * Forward Pharma - entitled to a non-refundable cash fee of 
us$1.25 billion within five business days of meeting pursuant to 
terms of license agreement 
 
Source text for Eikon:  ID:nGNXNPXTRa  
Further company coverage:  FWP.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))